APINAC
 | |
| Clinical data | |
|---|---|
| Other names | AKB-57, AKB57 |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C23H31N2O2 |
| Molar mass | 367.513 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
APINAC (AKB-57, N-(1-adamantyl)-1-pentylindazole-3-carboxylate) is a drug that acts as an agonist for the cannabinoid receptors.[2] It was detected in Slovenia in 2016[3] and is on the UNODC list of synthetic cannabinoids.[4]
Legality
[edit]APINAC is covered by the UK blanket ban on synthetic cannabinoids.
Detection
[edit]APINAC can be bought by labs as a reference standard.[5] APINAC metabolizes to N-pentylindazole-3-carboxylic acid, hydroxylated N-pentylindrazole-3-carboxylic acid, and 1-adamantanol in rats.[2]
See also
[edit]References
[edit]- ↑ Anvisa (2023-07-24). "RDC Nº 804 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 804 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-07-25). Archived from the original on 2023-08-27. Retrieved 2023-08-27.
- 1 2 Savchuk S, Appolonova S, Pechnikov A, Rizvanova L, Shestakova K, Tagliaro F (2017-07-01). "In vivo metabolism of the new synthetic cannabinoid APINAC in rats by GC–MS and LC–QTOF-MS". Forensic Toxicology. 35 (2): 359–368. doi:10.1007/s11419-017-0364-y. ISSN 1860-8973.
- ↑ "Analytical Report, AKB-57 (C23H30N2O2)" (PDF). NPS AND RELATED COMPOUNDS DATABASE. Slovenian National Forensic Laboratory (NFL) (published 2016-02-12). 2016-02-04.
adamantan-1-yl 1-pentyl-1H-indazole-3-carboxylate; KCCVWUAAHDXNNQ-UHFFFAOYSA-N
- ↑ "Substance Details AKB-57". www.unodc.org. Retrieved 2026-06-26.
- ↑ "Apinac (CAS 2219331-93-6)". Cayman. Retrieved 2026-06-26.